Sumitomo Parkinson’s Filing A Pivotal Moment For Japan’s iPSC Ambitions

US Trial Also Ongoing

Sumitomo's iPSC candidate for Parkinson's Disease
Sumitomo makes global-first approval filing for iPSC candidate for Parkinson's disease (Shutterstock)

More from Cell Therapies

More from Japan